A Yakima County resident exposed to infected dairy cattle has died of avian influenza. A third human case has also been confirmed as H5N1 spreads to 33 herds in the county.
|Articles|March 30, 2020
Contagion Live News Network: Coronavirus Updates for March 30, 2020
Author(s)Contagion® Editorial Staff
Stay up to date with our daily COVID-19 update.
Advertisement
Welcome to the Contagion Live News Network. I’m Grant Gallagher and this is the COVID-19 update for Monday, March 30th, 2020.
The United States has extended social distancing measures through the end of April, after reassessment of an earlier timeline floated which would begin to reopen the country by Easter.
Over the weekend, Contagion covered the need to prepare for patients to recover from COVID-19.
Harvard Medical School’s Daniel Grabowski, PhD noted that “Many patients with COVID-19 will need post-acute care to recuperate from their infection, however, post-acute care facilities currently lack the capacity and capability to safely treat patients with COVID-19 as they transition from the hospital to other care settings or to their homes."
The US Food and Drug Administration began working with diagnostic developers in January and to date has engaged with 230 test developers who have or are expected to submit requests for emergency use authorization. As of March 30th, 20 authorizations have been granted. Among these was a 5-minute diagnostic from Abbott. Additionally, more than 110 laboratories have notified the FDA that they have begun using their own tests.
The total number of cases in the US has now passed 153,000 with over 2800 deaths.
Around the world, there are over 760,000 cases. There have been over 36,000 reported deaths, but also at least 158,000 recoveries.
For other stories relevant to COVID-19 and the latest infectious disease news, visit ContagionLive.com. To track the spread of infectious diseases in the United States and abroad, be sure to use the Contagion
For the Contagion Live News Network, I’m Grant Gallagher. Thanks for listening.
Advertisement
Related to this article
Voceryq earned FDA accelerated approval for adults with RRP after 7 of 26 patients (27%) needed no surgery for 12 months in RRP-001; a confirmatory trial is required.
The latest CDC numbers show a 5.8% increase in measles cases from week-to-week, bringing the 2026 US total to more than double the amount seen in all of 2025 with 2 months left in the year.
Investigational agent Zelicapavir cut time to complete RSV symptom resolution by up to a week and lowered hospitalization in high-risk adults.
Alejandra Gurtman, MD, discussed the phase 2 data at IDWeek 2026 which showed the investigational 25-valent pneumococcal conjugate vaccine 25vPnC produced serotype 3 antibody levels about 15-fold higher than Prevnar 20 after the booster dose, targeting a serotype still behind 10.6% of invasive pneumococcal disease in US children younger than five years.
The latest CDC numbers show a 4.0% increase in measles cases from week-to-week, bringing the 2026 US total to 4588 confirmed cases. Ninety-six percent of cases are outbreak-associated.
In the phase 3b ENCORE trial, adding amikacin liposome inhalation suspension (ALIS) to azithromycin and ethambutol significantly improved culture conversion in newly diagnosed MAC lung disease, while treatment-emergent amikacin (2.2%) and macrolide (1.1%) resistance stayed rare. Kevin Winthrop, MD, provides insights around the study.
Oral zelicapavir cut time to complete RSV symptom resolution by up to 1 week in high-risk adults, but it did not meet its primary end point in a phase 2 trial.
Advertisement
Advertisement
Trending on Contagion Live
1
Nearly 30% of US Adults Report Misrepresenting Symptoms to Get Antibiotics
2
Washington State Reports First US Avian Influenza Death of 2026
3
FDA Tentatively Approves First Generic Lenacapavir PrEP for 120 LMICs
4
Postapproval Surveillance Confirms Ceftobiprole Activity Against MRSA
5